Cowen And Company, LLC Biogen Inc. Transaction History

Cowen And Company, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$222.59 - $267.94 $740,334 - $891,168	3,326 New	3,326 $860,000
Q4 2022 Feb 09, 2023	SELL	$252.44 - $306.72 $2.13 Million - $2.58 Million	-8,425 Reduced 77.12%	2,500 $692,000
Q3 2022 Nov 14, 2022	BUY	$194.69 - $268.46 $1.83 Million - $2.52 Million	9,389 Added 611.26%	10,925 $1.01 Million
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $15,940 - $18,956	-85 Reduced 5.24%	1,536 $313,000
Q1 2022 May 16, 2022	BUY	$193.77 - $244.14 $314,101 - $395,750	1,621 New	1,621 $341,000
Q3 2021 Nov 12, 2021	SELL	$282.99 - $369.05 $1.11 Million - $1.44 Million	-3,907 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$259.0 - $414.71 $1.01 Million - $1.62 Million	3,907 New	3,907 $1.35 Million

1,037

126M

1.13M

1.43M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.1B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Cowen And Company, LLC, based on Form 13F filings with the SEC.

Stay updated on Cowen And Company, LLC with notifications on news.